Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Nomizo, Takashi

Back to results

Kyoto University

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

dc:creator Nomizo, Takashi

dc:date.issued2019

Degree

thesis:*

Grantor dc:publisher: Kyoto University
Year dc:date.issued: 2019

Author and committee

dc:creator, dc:contributor.*

Author dc:creator: Nomizo, Takashi
Advisors dc:contributor.advisor: 松田, 文彦
清水, 章
濵﨑, 洋子

Subjects

dc:subject × 4

Rights

Language dc:language.iso: eng

Identifiers

dc:identifier.*

Handle dc:identifier.uri: http://hdl.handle.net/2433/242413
OAI identifier oai:identifier: oai:repository.kulib.kyoto-u.ac.jp:2433/242413

Chain of custody

source

Harvested from: Kyoto University
Base URL: repository.kulib.kyoto-u.ac.jp/server/oai/request
Last updated: 2026-07-24
Source record: OAI-PMH GetRecord

related terms

citation

Nomizo, Takashi. Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients. Kyoto University, 2019. http://hdl.handle.net/2433/242413

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Degree

Author and committee

Subjects

Rights

Identifiers

Chain of custody

More from Kyoto University